Medicine | Oncology
CNS Tumors | Gliomas
Diffuse midline gliomas | Treatment
Protein kinase inhibitors

Home > Disciplines > Medicine > Oncology > CNS Tumors > Gliomas > Diffuse midline gliomas > Treatment > Protein kinase inhibitors

Contents

Overview
Laboratory Investigations
Clinical investigations
■ Newly diagnosed tumors
■ Recurrent tumors
Miscellanea

Overview

Laboratory investigations

PPM1D INHIBITORS

.

Akamandisa MP, Nie K, Nahta R, Hambardzumyan D, Castellino RC.
Inhibition of mutant PPM1D enhances DNA damage response and growth suppressive effects of ionizing radiation in diffuse intrinsic pontine glioma.
Neuro Oncol. 2019 Mar 10. pii: noz053. doi: 10.1093/neuonc/noz053. [Epub ahead of print]
Source | Full text | Similar articles

Clinical investigations

Newly diagnosed tumors

Recurrent tumors

REGORAFENIB

.

Kebir S, Rauschenbach L, Radbruch A, Lazaridis L, Schmidt T, Stoppek AK, Pierscianek D, Stuschke M, Forsting M, Sure U, Keyvani K, Kleinschnitz C, Scheffler B, Glas M.
Regorafenib in patients with recurrent high-grade astrocytoma.
J Cancer Res Clin Oncol. 2019 Apr;145(4):1037-1042. doi: 10.1007/s00432-019-02868-5. Epub 2019 Feb 28.
Source | Full text | Similar articles

Miscellanea